Therapeutic Effects of Hyaluronic Acid on Osteoarthritis of the Knee: A Meta-Analysis of Randomized Controlled Trials

Journal of Bone and Joint Surgery

Volumn 86, Issue 3, 2004, Pages 538-545

  Wang, Chen Ti ^a   Lin, Jinn ^a   Chang, Chee Jen ^a   Lin, Yu Tsan ^a   Hou, Sheng Mou ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOHY; HYALURONIC ACID; PARACETAMOL;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; HUMAN; HYPERSENSITIVITY; KNEE OSTEOARTHRITIS; KNEE PAIN; META ANALYSIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VASCULITIS;

EID: 1442331599     PISSN: 00219355     EISSN: None     Source Type: Journal    
DOI: 10.2106/00004623-200403000-00012     Document Type: Article

References (55)

1. Felson DT, Zhang Y. An update on the epidemiology of knee and hip osteoarthritis with a view to prevention. Arthritis Rheum. 1998;41:1343-55.
2. Watterson JR, Esdaile JM. Viscosupplementation: therapeutic mechanisms and clinical potential in osteoarthritis of the knee. J Am Acad Orthop Surg. 2000;8:277-84.
3. Pendleton A, Arden N, Dougados M, Doherty M, Bannwarth B, Bljlsma JW, Cluzeau F, Cooper C, Dieppe PA, Gunther KP, Hauselmann HJ, Herrero-Beaumont G, Kaklamanis PM, Leeb B, Lequesne M, Lohmander S, Mazieres B, Mola EM, Pavelka K, Serni U, Swoboda B, Verbruggen AA, Weseloh G, Zimmermann-Gorska I. EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis. 2000;59:936-44.
4. Laurent TC, Fraser JR. Hyaluronan. FASEB J. 1992;6:2397-404.
5. Balazs EA, Watson D, Duff IF, Roseman S. Hyaluronic acid in synovial fluid. I. Molecular parameters of hyaluronic acid in normal and arthritis human fluids. Arthritis Rheum. 1967;10:357-76.
6. Peyron JG. A new approach to the treatment of osteoarthritis: viscosupplementation. Osteoarthritis Cartilage. 1993;1:85-7.
7. Rydell N, Balazs EA. Effect of intra-articular injection of hyaluronic acid on the clinical symptoms of osteoarthritis and on granulation tissue formation. Clin Orthop. 1971;80:25-32.
8. Henderson EB, Smith EC, Pegley F, Blake DR. Intra-articular injections of 750 kD hyaluronan in the treatment of osteoarthritis: a randomised single centre double-blind placebo-controlled trial of 91 patients demonstrating lack of efficacy. Ann Rheum Dis. 1994;53:529-34.
9. The Cochrane Controlled Trials Register. The Cochrane Library. Issue 4 ed. Update Software, 2001.
10. Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for systematic reviews. BMJ. 1994;309:1286-91.
11. Berlin JA. Does blinding of readers affect the results of meta-analyses? University of Pennsylvania Meta-analysis Blinding Study Group. Lancet. 1997;350:185-6. Letter.
12. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health. 1998;52:377-84.
13. Altman R, Brandt K, Hochberg M, Moskowitz R, Bellamy N, Bloch DA, Buckwalter J, Dougados M, Ehrlich G, Lequesne M, Lohmander S, Murphy WA Jr, Rosario-Jansen T, Schwartz B, Trippel S. Design and conduct of clinical trials in patients with osteoarthritis: recommendations from a task force of the Osteoarthritis Research Society. Results from a workshop. Osteoarthritis Cartilage. 1996;4:217-43.
14. de Craen AJ, Di Glulio G, Lampe-Schoenmaeckers JE, Kessels AG, Kleljnen J. Analgesic efficacy and safety of paracetamol-codeine combinations versus paracetamol alone: a systematic review. BMJ. 1996;313:321-5.
15. Zhang WY, Li Wan Po A. Analgesic efficacy of paracetamol and its combination with codeine and caffeine in surgical pain - a meta-analysis. J Clin Pharm Ther. 1996;21:261-82.
16. Zhang WY, Po AL. Do codeine and caffeine enhance the analgesic effect of aspirin? - A systematic overview. J Clin Pharm Ther. 1997;22:79-97.
17. McAlindon TE, LaValley MP, Gulin JP, Felson DT. Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. JAMA. 2000;283:1469-75.
18. Bradburn M, Deeks JJ, Altman DG. METAN - an alternative meta-analysis command. Stata Tech Bull. 1998;44:4-15.
19. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719-48.
20. OerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986:7:177-88.
21. Sharp S. Meta-analysis regression. Stata Tech Bull. 1998;42:16-22.
22. Altman RD, Moskowitz R. Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. Hyalgan Study Group. J Rheumatol. 1998;25:2203-12. Erratum in: J Rheumatol. 1999;26:1216.
23. Altman RD, Moskowitz R. Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. Hyalgan Study Group. J Rheumatol. 1998;25:2203-12. Erratum in: J Rheumatol. 1999;26:1216.
24. Bragantini A, Cassini M, De Bastiani G, Perbellini A. Controlled single-blind trial of intra-articularly injected hyaluronic acid (Hyalgan®) in osteo-arthritis of the knee. Clin Trials J. 1987;24:333-40.
25. Brandt KD, Block JA, Michalski JP, Moreland LW, Caldwell JR, Lavin PT. Efficacy and safety of intraarticular sodium hyaluronate in knee osteoarthritis. ORTHOVISC Study Group. Clin Orthop. 2001;385:130-43.
26. Carrabba M, Paresce E, Angelini M, Re KA, Torchiana EEM, Perbellini A. The safety and efficacy of different dose schedules of hyaluronic acid in the treatment of painful osteoarthritis of the knee with joint effusion. Eur J Rheumatol Inflamm. 1995;15:25-31.
27. Cohen MA, Shiroky JB, Ballachey ML, Neville C, Esdaile JM. Double-blind randomized trial of intra-articular (I/A) hyaluronate in the treatment of osteoarthritis of the knee. Arthritis Rheum. 1994;37(Suppl 9):R31.
28. Corrado EM, Peluso GF, Gigilotti S, De Durante C, Palmieri D, Savola M, Oriani GO, Tajana GF. The effects of intra-articular administration of hyaluronic acid on osteoarthritis of the knee: a clinical study with immunological and biochemical evaluations. EurJ Rheumatol Inflamm. 1995;15:47-56.
29. Creamer P, Sharif M, George E, Meadows K, Cushnaghan J, Shinmei M, Dieppe P. Intra-articular hyaluronic acid in osteoarthritis of the knee: an investigation into mechanisms of action. Osteoarthritis Cartilage. 1994;2:133-40.
30. Dickson J, Hosie G. Double-blind, double-control comparison of viscosupplementation with hylan GF 20 (Synvisc®) against diclofenac and control in knee osteoarthritis. Arthritis Rheum. 1998;41(Suppl 9):S197.
31. Dixon AS, Jacoby RK, Berry H, Hamilton EB. Clinical trial of intra-articular injection of sodium hyaluronate in patients with osteoarthritis of the knee. Curr Med Res Opin. 1988;11:205-13.
32. Dougados M, Nguyen M, Listrat V, Amor B. High molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: a 1 year placebo-controlled trial. Osteoarthritis Cartilage. 1993;1:97-103.
33. Sala SF, de Miguel RE. Intra-articular hyaluronic acid in the treatment of osteoarthritis of the knee: a short term study. Eur J Rheumatol Inflamm. 1995;15:33-8.
34. Grecomoro G, Martorana U, Di Marco C. Intra-articular treatment with sodium hyaluronate in gonarthrosis: a controlled clinical trial versus placebo. Pharmatherapeutica. 1987;5:137-41.
35. Huskisson EC, Donnelly S. Hyaluronic acid in the treatment of osteoarthritis of the knee. Rheumatology (Oxford). 1999;38:602-7.
36. Isdale AH, Hordon LD, Bird HA, Wright V. A controlled comparison of intraarticular Healon (hyaluronate), triamcinolone and saline in osteoarthritis of the knee. Br J Rheumatol. 1993;32(Suppl 1):61.
37. Russell IJ, Michalek JE, Lawrence VA, Lessard JA, Briggs BT, May GS. A randomized, placebo and no-intervention controlled, trial of intra-articular 1% sodium hyaluronate in the treatment of knee osteoarthritis. Arthritis Rheum. 1992;35(Suppl 9):S132.
38. Jubb RW, Piva S, Beinat L, Dacre J, Gishen P. Structure modifying study of hyaluronan (500-730 KDa, Hyalgan) on osteoarthritis of the knee. Arthritis Rheum. 2001;44(Suppl 9):S155.
39. Karlsson J, Selin-Sjogren L. A comparison of two hyaluronan drugs and placebo in patients with mild to moderate osteoarthritis of the knee - a controlled, randomised, parallel-design multicenter study. Acta Orthop Scand. 1999;70(Suppl 287):62.
40. Lohmander LS, Dalen N, Englund G, Hamalainen M, Jensen EM, Karlsson K, Odensten M, Ryd L, Sernbo I, Suomalainen O, Tegnander A. Intra-articular hyaluronan injections in the treatment of osteoarthritis of the knee: a randomised, double blind, placebo controlled multicentre trial. Hyaluronan Multicentre Trial Group. Ann Rheum Dis, 1996;55:424-31.
41. Moreland LW, Arnold WJ, Saway A, Savory C, Sikes D. Efficacy and safety of intra-articular hylan G-F 20 (Synvisc®), a viscoelastic derivative of hyaluronan, in patients with osteoarthritis of the knee. Arthritis Rheum. 1993;36(Suppl 9):S165.
42. Puhl W, Bernau A, Greiling H, Köpcke W, Pförringer W, Steck KJ, Zacher J, Schaff HP. Intra-articular sodium hyaluronate in osteoarthritis of the knee: a multicenter double-blind study. Osteoarthritis Cartilage. 1993;1:233-41.
43. Scale D, Wobig M, Wolpert W. Viscosupplementation of osteoarthritic knees with hylan: a treatment schedule study. Curr Ther Res Clin Exp. 1994;55:220-32.
44. Tamir E, Robinson D, Koren R, Agar G, Halperin N. Intra-articular hyaluronan injections for the treatment of osteoarthritis of the knee: a randomized, double blind, placebo controlled study. Clin Exp Rheumatol. 2001;19:265-70.
45. Wobig M, Dickhut A, Maier R, Vetter G. Viscosupplementation with hylan G-F 20: a 26-week controlled trial of efficacy and safety in the osteoarthritic knee. Clin Ther. 1998;20:410-23.
46. Wu JJ, Shih LY, Hsu HC, Chen TH. The double-blind test of sodium hyaluronate (ARTZ) on osteoarthritis knee. Zhonghua Yi Xue Za Zhi (Taipei). 1997;59:99-106.
47. Schiavinato A, Finesso M, Cortivo R, Abatangelo G. Comparison of the effects of intra-articular injections of Hyaluronan and its chemically cross-linked derivative (Hylan G-F20) in normal rabbit knee joints. Clin Exp Rheumatol. 2002;20:445-54.
48. Bekelman JE, Li Y, Gross CP. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA. 2003;289:454-65.
49. Lexchin J, Bero LA, Djulbegovic B, Clark O. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ. 2003;326:1167-70.
50. Puttick MP, Wade JP, Chalmers A, Connell DG, Rangno KK. Acute local reactions after intraarticular hylan for osteoarthritis of the knee. J Rheumatol. 1995;22:1311-4.
51. Martens PB. Bilateral symmetric inflammatory reaction to hylan G-F 20 injection. Arthritis Rheum. 2001;44:978-9.
52. Chen AL, Desai P, Adler EM, Di Cesare PE. Granulomatous inflammation after Hylan G-F 20 viscosupplementation of the knee: a report of six cases. J Bone Joint Surg Am. 2002;84:1142-7.
53. Leopold SS, Warme WJ, Pettis PD, Shott S. Increased frequency of acute local reaction to intra-articular hylan GF-20 (Synvisc) in patients receiving more than one course of treatment. J Bone Joint Surg Am. 2002;84:1619-23.
54. Egger M, Zellweger-Zahner T, Schneider M, Junker C, Lengeler C, Antes G. Language bias in randomised controlled trials published in English and German. Lancet. 1997;350:326-9.
55. Pittler MH, Abbot NC, Harkness EF, Ernst E. Location bias in controlled clinical trials of complementary/alternative therapies. J Clin Epidemiol. 2000;53:485-9.